Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
16 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.80
Open
$1.80
Day's High
$1.80
Day's Low
$1.75
Volume
8,629
Avg. Vol
32,143
52-wk High
$5.25
52-wk Low
$1.58

Chart for

About

Cancer Genetics, Inc. is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $49.87
Shares Outstanding(Mil.): 27.70
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.50 17.27
EPS (TTM): -- -- --
ROI: -- 6.26 35.43
ROE: -- 9.84 17.10

BRIEF-Cancer Genetics Receives Non-Dilutive Funding Of $1.1 Mln

* CANCER GENETICS RECEIVES NON-DILUTIVE FUNDING OF $1.1 MILLION THROUGH NEW JERSEY TECHNOLOGY BUSINESS TAX CERTIFICATE TRANSFER (NOL) PROGRAM

Dec 28 2017

BRIEF-Stonepine Capital Management Reports 5 Percent Passive Stake In Cancer Genetics

* STONEPINE CAPITAL MANAGEMENT REPORTS 5 PERCENT PASSIVE STAKE IN CANCER GENETICS INC AS ON DEC 12 - SEC FILING Source: (http://bit.ly/2p5v6Mx) Further company coverage:

Dec 21 2017

BRIEF-Cancer Genetics Prices $7 Million Registered Direct Offering

* CANCER GENETICS PRICES $7 MILLION REGISTERED DIRECT OFFERING

Dec 08 2017

BRIEF-Cancer Genetics Q3 loss per share $0.15

* Cancer genetics reports record third quarter 2017 revenue and 134% increase in contracted bookings from major biotech and pharmaceutical companies

Nov 09 2017

Competitors

Earnings vs. Estimates